The modifying effect of dietary administration of auraptene isolated from the peel of citrus fruit (Citrus natsudaidai Hayata) on the development of azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) was investigated in rats. Male F344 rats were given s.c. injections of AOM (15 mg/kg body wt) once a week for 3 weeks to induce ACF. They also received diets containing 100 or 500 p.p.m. auraptene for 5 weeks, starting 1 week before the first dose of AOM. At termination of the study (week 5) dietary administration of auraptene caused a significant reduction in the frequency of ACF in a dose-dependent manner (P Ͻ 0.05). Feeding of auraptene suppressed expression of cell proliferation biomarkers (5-bromo-2Ј-deoxyuridine labeling-index, ornithine decarboxylase activity, polyamine content and number of silver stained nucleolar organizer region protein particles) in the colonic mucosa and the occurrence of micronuclei caused by AOM. Also, auraptene increased the activities of phase II enzymes (glutathione Stransferase and quinone reductase) in the liver and colon. These findings might suggest that inhibition of AOMinduced ACF may be associated, in part, with increased activity of phase II enzymes in the liver and colon and suppression of cell proliferation in the colonic mucosa.
Introduction
Colon cancer is the third most malignant neoplasm in the world (1) and the second leading cause of cancer deaths in the USA. In Japan colon cancer incidence has been increasing, being the third leading cause of cancer death. It is well known that dietary factors can modulate the development of certain types of human cancer, including colon cancer (2) . There is an inverse correlation between the intake of fruits/vegetables and human colon cancer (3) . In this context, primary prevention, including chemoprevention utilizing the active compounds in fruits and vegetables, is important for reducing this malignancy.
Aberrant crypt foci (ACF*) are considered to be preneoplastic lesions since they are present in carcinogen-treated rodent colons and in human colons with a high risk of cancer development (4, 5) . This aspect of ACF favors their use as biomarkers for investigating modulation of colon carcinogenesis (6, 7) . A number of natural compounds that inhibit ACF development induced by exposure to several colon carcinogens have been proved as chemopreventive against colon cancer in rodents (6, 8) . Limonene, which is a monocyclic monoterpene found in the essential oils of citrus fruits, spices and herbs, is known to be an inhibitor of chemically induced skin, breast, forestomach, lung and liver carcinogenesis in rodents (for a review see 9) . It has also been reported that limonene induces nephrotoxicity in male rats harboring α 2u -globulin (10) . Ninety to 95% of limonene is found in orange peel. Recently our group have found that d-limonene causes a 32% reduction in the frequency of ACF induced by azoxymethane (AOM) (11) and have suggested a possible cancer chemopreventive action against colon cancer in addition to breast cancer. Hesperidin, another compound in the peel of citrus fruits, could also effectively suppress ACF development (61% reduction) (8) and has been found to inhibit AOMinduced colon carcinogenesis (12) . A known coumarin, auraptene (Figure 1) , is also present in certain orange peels, but in small amounts: 0.04% in Citrus natsudaidai Hayata, 0.01-0.02% in grapefruit and 180 µg/100 ml in grapefruit juice. Although antiplatelet action of this compound has been reported (13), other biological activities, including modulatory effects on tumorigenesis in digestive organs, are not known. Coumarin and other coumarin derivatives, for example hydroxycoumarin, are reported to have anticarcinogenic effects (14) (15) (16) (17) (18) . There is also evidence that coumarin can induce SV40 amplification in transformed cells (19) or acts as a hepatocarcinogen or a liver tumor promoter (20) . Recently, antipromoting effects of auraptene on 7,12-dimethylbenz[a]anthracene-induced mouse skin tumorigenesis has been found (21) . Also, auraptene markedly suppressed superoxide generation induced by 12-Otetradecanoylphorbol 13-acetate in differentiated human promyelocytic HL-60 cells (21) .
In the present study a possible modifying effect of auraptene on the development of AOM-induced colonic ACF was investigated in male F344 rats. The biomarkers 5-bromo-2Ј-deoxyuridine (BrdU)-labeled nuclei and silver stained nucleolar organizer region protein (AgNORs) of colonic epithelial cells, ornithine decarboxylase (ODC) activity and polyamine levels in the colonic mucosa were also examined. In addition, the frequency of micronuclei in the colonic epithelium of rats exposed to AOM with or without auraptene feeding was assessed to evaluate carcinogen-induced damage and modification of some initiating events by the test chemical (22) . Since certain chemopreventive agents exert their inhibitory effects on carcinogenesis through increased activities of phase II enzymes such as glutathione S-transferase (GST) and quinone reductase (QR) (23-27), the effect of auraptene on GST and QR activities was measured in the liver and colonic mucosa.
Materials and methods

Animals, test chemical and diet
A total of 75 male F344 rats, 4 weeks old, obtained from Japan SLC Inc. (Hamamatsu City, Japan), were used for this experiment. Animals were housed three or four to a wire cage in an experimental room under controlled conditions of 23 Ϯ 2°C, 50 Ϯ 10% humidity and a 12 h light/dark cycle. They were allowed ad libitum access to food and water. Powdered CE-2 (CLEA Japan Inc., Tokyo, Japan) was used as the basal diet during the experiment, containing 50.4% crude carbohydrate, 24.8% crude protein, 4.6% crude fat, 7.2% ash, 4.2% crude cellulose, 8.8% water and 4.04% minerals. To isolate auraptene, natsumikans (Wakayama Prefecture) were harvested in 1994 and whole parts (4.8 kg fresh wt) were processed using a FMC Citrus Juice Extractor (FMC Co., Switzerland) to give the cold-pressed oils (9.5 g). The oils thus obtained were fractionated by silica gel (n-hexane/ethyl acetate, stepwise method) and high performance column chromatography (19ϫ150 mm, elute 90% methanol in water, flow rate 7.0 ml/min, detection at UV 254 nm , retention time 12.2 min, column µBondas-phere C18; Waters, MA). Auraptene (240 mg) was recrystallized from ethanol and identified by several spectroscopic analyses (UV, infrared, proton and carbon nuclear magnetic resonance and mass spectra). The spectral data were identical to those previously reported (28) .
ACF assay and analysis of cell proliferation biomarkers and micronuclei
After quarantine for 1 week, 52 rats aged 5 weeks were divided into five groups as shown in Figure 2 . Starting at 6 weeks of age, animals in groups 1-3 were s.c. injected with AOM (15 mg/kg body wt; Sigma Chemical Co., St Louis, MO) once a week for 3 weeks to induce colonic ACF. Rats in groups 2-4 were given the basal diet containing 100 or 500 p.p.m. auraptene for 5 weeks, beginning at 5 weeks of age. Groups 1 and 5 were fed the basal diet throughout the study. Animals were weighed weekly. At termination of the study (week 5) all rats were killed by decapitation. Three rats from each group were randomly selected for measurement of ODC activity and polyamine levels in the colonic mucosa. The remaining animals were used for detection of colonic ACF and assessment of BrdU labeling index, AgNORs number and micronuclei. They were given an i.p. injection of BrdU (50 mg/kg body wt; Sigma Chemical Co., St Louis, MO) 1 h prior to killing. The removed 2156 colons for detection of ACF were cut open longitudinally from cecum to anus, placed between two pieces of filter paper and fixed in 10% buffered formalin for 24 h. Then they were stained with 0.5% methylene blue in saline to observe ACF, as described previously (29) . Colons were then dissected into three portions (proximal, middle and distal colon) and used for counting ACF. After observation they were embedded in paraffin and sliced at 3 µm thickness. The sections were used for histological examination, BrdU immunohistochemistry and micronucleus assay. For determination of BrdU incorporation BrdU immunohistochemistry was performed according to the method described previously (30) . Twenty well-shaped crypts of colonic epithelium were selected and used for counting BrdU-labeled nuclei and cells containing micronuclei. To identify micronuclei sections were stained with Feulgen/fast green (31, 32) . Colons for measurement of tissue polyamine levels were immediately removed, slit open longitudinally and freed from all contents. The colonic mucosa was scraped with a knife blade and stored at -70°C. Proteins were extracted from the mucosa and then polyamine levels and ODC activity in the extract were determined by methods described previously (30, 33) . GST and QR assay Twenty rats aged 5 weeks were used for GST and QR assay. They received a single dose of 200 mg/kg auraptene in 0.5 ml 5% gum arabic (Sigma Chemical Co.) by gavage. They were killed by cervical dislocation at 3, 12, 24, 48 and 72 h after auraptene administration. Controls (three rats) were gavaged with 0.5 ml vehicle (gum arabic) alone and then killed 3 h after gavage. At sacrifice the livers and colons were immediately excised. The liver was perfused with saline to remove blood and minced into small pieces. The colon was slit longitudinally and washed with phosphate-buffered saline, pH 7.4, and the mucosa collected by scraping the mucosal surface using a microscope knife. Samples of minced liver and mucosal scrapings were processed to obtain the cytosolic fraction as described (34, 35) . The activities of GST with 1-chloro-2,4-dinitrobenzene as substrate and QR with NADH and menadione as substrates were determined as described previously (36) (37) (38) . All assays were performed by spectrophotometry at 340 nm and all samples were measured in quadruplicate. One unit of enzyme activity is the amount of enzyme catalyzing conversion of 1 µmol substrate to product per min at 25°C. Cytosolic protein concentrations were determined by the Bradford method (39) using bovine serum albumin as standard. Statistics All data are presented as means Ϯ SD. The body weight, liver weight and all measurements were compared by Student's t-test for unpaired samples. Differences with P Ͻ 0.05 were considered significant.
Results
General observation
Mean body and liver weights in all groups are shown in Table  I . The average body weight in group 3 was significantly lower than that in group 1 (P Ͻ 0.001). The mean liver weight in group 1 was significantly smaller than group 5 (P Ͻ 0.001).
The mean liver weight in group 2 was significantly greater than group 1 (P Ͻ 0.05). Food intake/day/rat was comparable among the groups (data not shown). During this study (5 weeks) clinical signs of toxicity, low survival and poor condition were not present in any group. Histologically there were no toxic changes in liver, kidneys and lungs of rats given the test compound.
ACF assay
The data on ACF are also summarized in Table I . In group 1 AOM induced 157 Ϯ 21 ACF/rat. Dietary administration of auraptene caused a significant reduction in ACF incidence: 93 Ϯ 4 in group 2 (P Ͻ 0.001) and 69 Ϯ 6 in group 3 (P Ͻ 0.001). A significant decrease in the number of ACF per cm 2 , total number of aberrant crypts per colon and number of aberrant crypts per focus in groups 2 and 3 was also observed when compared with those in group 1 (P Ͻ 0.001). Such a reduction was dose dependent. There were no ACF in the colons of rats without AOM injection (groups 4 and 5). The distribution and frequency of ACF in groups 1-3 are illustrated in Figure 3 . The order of frequency of ACF in these groups was distal colon Ͼ middle colon Ͼ proximal colon and auraptene significantly inhibited the occurrence of ACF in all regions (P Ͻ 0.001). The size of ACF which developed in rats exposed to AOM and AOM ϩ auraptene are indicated in 2157 Figure 4 . Dietary feeding of auraptene significantly reduced all numbers of ACF (P Ͻ 0.001).
Expression of cell proliferation biomarkers and the micronucleus assay
The incidences of micronuclei, BrdU-labeling index and AgNORs number at the end of the study are presented in Table II . All these values in group 1 were significantly greater than those in group 5 (P Ͻ 0.01 or P Ͻ 0.001). Feeding of auraptene at both doses significantly reduced these values (P Ͻ 0.05-P Ͻ 0.001). The results for ODC activity and polyamine levels in the colonic mucosa are also indicated in Table II . AOM treatment significantly increased mucosal ODC activity and polyamine content (PϽ0.005 and PϽ0.05). Dietary administration of auraptene in groups 2 and 3 decreased this increase in ODC activity and polyamine level (P Ͻ 0.01 and P Ͻ 0.05).
QR and GST activities
Data from the QR and GST assays are illustrated in Figures  5 and 6 . QR activities in the liver (Figure 5a ) and colon ( Figure 5b) were not increased immediately after a single oral administration of auraptene, however, liver QR activity increased 24 h (18% over control) and colonic QR activity 72 h (21% over control) after auraptene exposure. Elevated QR activity in the liver continued over a 48 h period (26% over control) and then decreased. The increase in QR activity at 72 h in the colon was significant when compared with the control (P Ͻ 0.005). Liver GST activity (Figure 6a ) was significantly increased by 30% (P Ͻ 0.001) and 33% (P Ͻ 0.002), 3 and 24 h after auraptene exposure respectively. Colonic mucosal GST activity (Figure 6b ) increased at all the sacrifice points when compared with the control (3 h, 26% increase, P Ͻ 0.01; 12 h, 23% increase, P Ͻ 0.01; 24 h, 21% increase, P Ͻ 0.001; 48 h, 35% increase, P Ͻ 0.001; 72 h, 48% increase, P Ͻ 0.001).
Discussion
The results in the present study indicate that dietary feeding of auraptene effectively suppresses the occurrence of ACF induced by AOM when administered during carcinogen treatment. ACF are considered to be possible precursor lesions for colon cancer in rodents and humans (4) . We and other investigators have used this model for screening chemopreventive agents against colon cancer (6, 8, 40, 41) . The results described here suggest that a known coumarin, auraptene, 2158 present in citrus fruits, might have chemopreventive effects on colon carcinogenesis, although a long-term experiment, which is under way in our laboratory, is needed to confirm the present findings. As pointed out by Wattenberg (42) and Talalay (43) , several mechanisms by which chemopreventive agents exert their inhibitory effects on tumorigenesis could be considered. Metabolic activation of AOM to a reactive species capable of alkylating DNA occurs through hydroxylation of AOM to methylazoxymethanol in the liver and metabolism of methylazoxymethanol to a highly reactive electrophile (the methyldiazonium ion, the ultimate carcinogen, which can methylate cellular nucleophiles, including DNA) occurs in liver and colon (44, 45) . Several colon tumor inhibitors, including disulfiram, have been reported to alter AOM metabolism and inhibit tumorigenicity (8, (46) (47) (48) . Certain organosulfur compounds, including oltipraz, also exert their chemopreventive potential by this mechanism (49) . In the present study auraptene reduced the frequency of micronuclei induced by AOM exposure, 6 . Effect of auraptene on GST activity in the liver (a) and colon (b). Rats were administered auraptene (200 mg/kg body wt) and killed at the times described in Materials and methods. *P Ͻ 0.001, **P Ͻ 0.002, ***P Ͻ 0.01.
suggesting the possibility that feeding with an auraptenesupplemented diet during AOM treatment modulates liver and intestinal metabolism of AOM. As observed in the present study, administration of auraptene significantly increased the activities of the detoxification enzymes QR and GST in the liver and colon. These observations are in agreement with other chemopreventive agents, including organosulfur compounds and antioxidants (24) (25) (26) (27) 36, 50) . Thus, auraptene may be classified as a 'blocking' chemopreventive agent (51). Interestingly, a decreased level of GST activity in blood lymphocytes was found in humans at increased risk of colon cancer and correlated with the levels of activity in their colonic mucosa (52) .
Auraptene is reported to have antiplatelet action and a strong antioxidative effect. Certain chemopreventers, including those with antioxidative activity, could alter increases in biomarkers induced by carcinogen treatment (31, 32, 53, 54) . In the present study expression of cell proliferation biomarkers such as ODC activity, polyamine level and AgNORs number estimated in the colonic mucosal epithelium was significantly inhibited by 2159 dietary feeding of this chemical. Thus the inhibitory effect of auraptene may be due to modification of cell proliferation in the colonic mucosa through the above-mentioned mechanism(s).
In summary, dietary administration of auraptene significantly suppressed development of AOM-induced rat colonic ACF, in conjunction with a reduction in the frequency of micronuclei, expression of cell proliferation biomarkers and activities of the phase II enzymes QR and GST in the target organ. Although the exact mechanisms involved in such inhibitory effects and the toxicity of the compound need to be determined, the results described here should provide a stimulus to further studies on the modifying effects of this compound on the initiation and post-initiation phases of colon carcinogenesis using a longterm bioassay system and on the mechanisms of modification of colon tumorigenesis. Such studies are on-going in our laboratory.
